How Is The Market Feeling About Halozyme Therapeutics?
Portfolio Pulse from Benzinga Insights
Halozyme Therapeutics (NYSE:HALO) has seen a 3.46% increase in its short percent of float, now at 9.57%. This indicates a bearish sentiment, although it remains below the peer group average of 12.43%.
August 20, 2024 | 1:15 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Halozyme Therapeutics has experienced a 3.46% increase in short interest, now at 9.57% of its float. This suggests a bearish market sentiment, although it is still below the peer average of 12.43%.
The increase in short interest suggests that investors are becoming more bearish on Halozyme Therapeutics. However, since the short interest is still below the peer average, the bearish sentiment may not be as strong as it could be. This could lead to downward pressure on the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100